53.35
1.68%
-0.91
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Ani Pharmaceuticals Inc Azioni (ANIP) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
4.39%
137.43
|
131.65 | 131.83 | 116.55 | 106.79 |
Operating Expenses
|
6.25%
117.12
|
124.93 | 113.88 | 104.14 | 96.89 |
Benefits Costs and Expenses |
14.24%
112.09
|
130.71 | 120.32 | 111.30 | 104.62 |
Costs And Expenses |
6.25%
117.12
|
124.93 | 113.88 | 104.14 | 96.89 |
Depreciation and Amortization |
3.34%
14.69
|
15.19 | 15.21 | 14.69 | 14.70 |
Operating Income/Loss |
201.99%
20.31
|
6.726 | 17.95 | 12.40 | 9.895 |
Income/Loss From Continuing Operations Before Tax |
2,575%
25.34
|
0.947 | 11.51 | 5.249 | 2.165 |
Income Tax Expense/Benefit |
3,527%
7.128
|
-0.208 | 1.571 | -0.996 | 0.726 |
Income/Loss From Continuing Operations After Tax |
1,476%
18.21
|
1.155 | 9.94 | 6.245 | 1.439 |
Net Income/Loss
|
1,476%
18.21
|
1.155 | 9.94 | 6.245 | 1.439 |
Preferred Stock Dividends And Other Adjustments |
0.00%
0.406
|
0.406 | 0.406 | 0.407 | 0.406 |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
5,551%
19.10
|
0.338 | 18.88 | 17.69 | 16.39 |
Diluted Average Shares |
5,135%
19.42
|
0.371 | 19.12 | 17.86 | 16.53 |
Basic Earnings Per Share |
4,100%
0.84
|
0.02 | 0.46 | 0.30 | 0.06 |
Diluted Earnings Per Share |
4,000%
0.82
|
0.02 | 0.45 | 0.29 | 0.06 |
Undistributed Earnings/Loss Allocated To Participating Securities, Basic |
3,510%
1.805
|
0.05 | 0.891 | 0.589 | 0.113 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
384.87%
2.211
|
0.456 | 1.297 | 0.996 | 0.519 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):